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Abstract
Predicting health outcomes from longitudinal health histories is of central importance to
healthcare. Observational healthcare databases such as patient diary databases provide
a rich resource for patient-level predictive modeling. In this paper, we propose a Bayesian
hierarchical vector autoregressive (VAR) model to predict medical and psychological
conditions using multivariate time series data. Compared to the existing patient-specific
predictive VAR models, our model demonstrated higher accuracy in predicting future
observations in terms of both point and interval estimates due to the pooling effect of the
hierarchical model specification. In addition, by adopting an elastic-net prior, our model
offers greater interpretability about the associations between variables of interest on both
the population level and the patient level, as well as between-patient heterogeneity. We
apply the model to two examples: 1) predicting substance use craving, negative affect and
tobacco use among college students, and 2) predicting functional somatic symptoms and
psychological discomforts.
1 Introduction
Analyses of patient-level observational healthcare databases underpin much of the current
evidence base for healthcare practice. Administrative claims, electronic health record (EHR),
and patient diary databases in particular have seen increased use in the past decade owing to
greater availability at lower costs and technological advances that made computational pro-
cessing on large-scale data more feasible [1]. Because the data reflect healthcare activity within
a real-world population, they offer the potential to complement clinical trial results. Adminis-
trative claims databases have been the most actively used observational healthcare data source.
These databases typically capture data elements used within the reimbursement process, as
providers of healthcare services (e.g., physicians, pharmacies, hospitals, and laboratories) must
submit encounter information to enable payment for their services [2].
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Neither administrative claims nor EHRs represent the ideal information required to gener-
ate reliable evidence. For example, diagnoses recorded on medical claims are used to support
justification for the payment for a given visit or procedure and “up-coding” may occur, or, a
given diagnosis could represent the condition that the procedure was used to rule out or could
be an administrative artifact. Some diagnosis codes have been studied through source record
verification and have demonstrated impressive performance characteristics (see, for example,
[3], or [4]), whereas other conditions and systems provide less certainty (see, for example, [5],
[6], or [7]). Limitations exist in EHR systems as well, in which, apart from concerns about
incomplete capture, data may be artificially manipulated to serve clinical care (e.g., an incor-
rect diagnosis recorded to justify a desired medical procedure).
Patient diary databases capture fewer variables and smaller numbers of patients but offer
significant advantages. In particular, diaries can capture longitudinal data about activities
of daily living, mood, and personal habits and not just when a patient is seeking healthcare.
Patient diaries support significant research activities in chronic disease management [8], [9],
[10]. Electronic patient diaries capture data via a web interface or a phone or tablet and repre-
sent the most common modality. Participating patients make diary entries either daily or at
multiple times per day, or at set intervals.
Major use cases for observational healthcare databases include inferences about the causal
effects of healthcare interventions (typically via cohort, case-control, or self-controlled case
series designs), healthcare characterization (see, for example, [11]), and patient-level predictive
modeling (PLPM), the primary focus of this paper. PLPM lies right at the core of healthcare
practice and so-called precision medicine. At least implicitly, every healthcare intervention
decision involves a patient-level prediction.
Many researchers have considered the problem of developing predictive models from
patient-level data (see, for example, [12], [13]). In the vast majority of cases, researchers gener-
ated a set of candidate covariates thought to be related to the outcome of interest and employed
traditional statistical or machine learning algorithms to predict the outcome using these covar-
iates. The authors of He et al. (2014), for example, predict hospital readmissions using logistic
regression with a modified forward variable selection algorithm to choose features from the set
of all indicator variables for any past occurrence of a medical concept with a diagnostic code
[14]. None of the features in their study, however, conveys any information about time. This is
the same for a few other studies that utilized similar approaches to predict medical conditions
such as asthma [15], cardiovascular diseases [16] and hypertension disorders [17].
Some authors have attempted to incorporate explicit temporal information into patient-
level predictive models. In the context of stroke prediction, Shahn et al. (2015) proposed a
“relational random forests” (RRF) that capture “motifs” in the medical history that are predic-
tive of specific future events [18]. Motifs capture healthcare episodes such as “received drug X
or diagnosis Y then suffered condition Z within T days.” In their target application, RRF
showed modest benefits in predictive performance. Wang et al. (2012) consider a patient’s
health history as the superposition and concatenation of multiple pattern matrices [19]. Each
pattern matrix specifies a rigid temporal relationship among health events that repeats over
time. They employ a matrix factorization algorithm to learn the pattern matrices, which can
then be used to construct features for predictive models. Brzan et al (2017) show that incorpo-
ration of historical patient data improves predictive performance for hospital readmission pre-
diction [20].
In this paper, we approach PLPM as a multivariate time series modeling problem and con-
sider a temporal generative model for the medical record. We adopt a Bayesian approach and
consider applications to patient diary data in the context of drug and alcohol treatment and
functional somatic symptoms. We explore the predictive performance of this model. Since the
Bayesian VAR for PLPM
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model offers advantages in terms of interpretability as compared with alternatives such as ran-
dom forests and deep learning, we explore insights derived from the model.
2 Vector autoregressive models for patient data
Vector autoregressive (VAR) models represent a mainstay of multivariate time analysis [21].
Previous studies have applied VAR models to patient diary data (see, for example, [22] and
[23]). However, these studies fit separate models for each individual patient and have a few
limitations. The patient-specific VAR coefficient estimates, for example, could have large vari-
ance (or even spurious estimates) when the number of observations for a particular patient is
small relative to the number of parameters in the coefficient matrices, leading to potentially
high variance in future data prediction. Further, to analyze between-subject heterogeneity,
existing methods utilize ad-hoc approaches such as clustering analysis on the patient-specific
VAR coefficient estimates [22]. This is, however, statistically sub-optimal due to loss of infor-
mation by using coefficient estimates rather than the original data. Moreover, no quantifica-
tion of the between-subject heterogeneity is provided.
Here we take a Bayesian approach and simultaneously model all patients using a hierarchi-
cal model. Bayesian VARmodels have been widely applied in various fields of study such as
economics [24], [25], [26], neuroimaging [27] and more recently psychology [28]. We adopt a
flexible elastic-net prior to induce sparsity in the estimation of the coefficients and to aid
interpretability [29]. Specifically, this prior is able to select the most predictive variables in the
model and remove unimportant ones, leading to a model with a smaller number of important
variables and thus higher interpretability. The hierarchical structure for the subject-level coef-
ficients enables simultaneous inference about both the population-level and the subject-level
coefficients and, in our target application, improves predictive performance. Our approach
also enables estimation of between-subject heterogeneity in a quantitative way by contrast
with the current clustering analysis, leading to higher interpretability of these parameters.
2.1 Sparse hierarchical VARmodel
Let N denote the number of patients. We assume that each patient records diary measurements
at Tn time points, n = 1, . . ., N on R variables. In what follows we assume daily measurements.
Let ynt = (ynt1, . . ., yntR)
T be a column vector representing the measurements at time t, t = 1, . . .,
Tn, for patient n, n = 1, . . ., N. Then, for each patient, the sparse hierarchical VAR(p) model
assumes
ynt ¼
Xp
i¼1
Aniyn;t i þ ŀnt; t ¼ pþ 1; . . . ;Tn ð1Þ
where Ani, i = 1, . . ., p is a R × R coefficient matrix representing the lag-i association, p is the
model order, i.e., the total number of past time steps used as predictors, and ŀnt is the error
term assumed to follow i.i.d. multivariate Normal (MVN) distribution with mean 0 and preci-
sion matrix ö: ŀnt�MVN(0, ö−1). We write the model in concise matrix form as:
yn ¼ ðH
T
n � IBÞwn þ ŀn ð2Þ
where
yn ¼
yn;pþ1
.
.
.
ynTn
0
BB@
1
CCA ð3Þ
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is the response variable and� is the Kronecker product,
Hn ¼
ynp � � � yn;Tn 1
.
.
.
.
.
.
.
.
.
yn1 � � � yn;Tn p
0
BBB@
1
CCCA ð4Þ
represents the regressors,
wn ¼ vecð½An1; . . . ;Anp�Þ ð5Þ
is the vectorized coefficients of length R2 p,
ŀn ¼
ŀn;pþ1
.
.
.
ŀnTn
0
BB@
1
CCA � MVNð0; ITn p � L 1Þ ð6Þ
is the stacked error term, and Ik represents a k × k identity matrix.
Here we assume that the precision matrix ö is the same for all patients but the coefficient
vector wn is unique for patient n. Specifically, we assume that the coefficient vector for the n-th
patient comprises two parts:
wn ¼ w þ vn ð7Þ
where w, is the population-level coefficient and is the same across all patients, vn is the patient-
level coefficient for the n-th patient.
For the population-level coefficient, we adopt the doubly adaptive elastic-net prior [29].
Specifically, we assume that the prior for w follows a multivariate Normal distribution with
mean 0 and precision matrix D:
wjD � MVNð0;D 1Þ ð8Þ
where D is a diagonal matrix and the diagonal elements depend on hyperparameters 2t2k and
ĕ2,k > 0, k = 1, . . ., R2 p:
diagðDÞ ¼ l
2;1
þ
1
2t2
1
; . . . ; l
2;R2p þ
1
2t2
R2p
 !
ð9Þ
Here 2t2k; k ¼ 1; . . . ;R
2p is assumed to follow independent Exponential distribution with rate
parameter
l
2
1;k
2x2
k
:
2t2kj2x
2
k; l1;k � E
l
2
1;k
2x
2
k
 !
ð10Þ
where ĕ1,k > 0, k = 1, . . ., B2 p, and x2k; k ¼ 1; . . . ;R2p, depends on the error precision matrix
Bayesian VAR for PLPM
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ö through:
x
2
k ¼ Mk;k   Mk;kþ1; . . . ;Mk;R2p
� � Mkþ1;kþ1 � � � Mkþ1;R2p
.
.
.
.
.
.
.
.
.
MR2p;kþ1 � � � MR2p;R2p
0
BBB@
1
CCCA
 1
Mk;kþ1
.
.
.
Mk;R2p
0
BBB@
1
CCCA ð11Þ
M ¼ IRp � L
 1
: ð12Þ
We also assume that ĕ1,k and ĕ2,k, k = 1, . . ., R2 p follow two i.i.d. Gamma distributions:
l
1;k � Gðm1; n1Þ ð13Þ
l
2;k � Gðm2; n2Þ ð14Þ
where μ1, ν1, μ2, ν2 are the corresponding mean and degree of freedom parameters which are
assumed to be known. Here, ĕ1,k and ĕ2,k represent the L1 and L2 tuning parameters for the k-
th element of w, respectively. It can be shown that the conditional distribution for each of the
elements of w given the error precision matrix ö comprise a Normal distribution and a Laplace
distribution. In other words, this prior generalizes the adaptive Lasso and provides adaptive
shrinkage for the elastic-net regularization. Note that conditioning on the error precision
matrix ö is important as it ensures unimodal posterior distribution for each of the elements of
w [30].
For the patient-level coefficients, we apply conjugate i.i.d. multivariate Normal priors with
mean 0 and diagonal precision matrix óv:
vnjYv � MVNð0;Y
 1
v Þ ð15Þ
for n = 1, . . ., N, where the diagonal elements ofóv are
diagðYvÞ ¼ ðyv1; . . . ; yv;R2pÞ ð16Þ
for which we apply the Gamma hyperpriors on each of the diagonal elements θvk, k = 1, . . ., R
2
p, i.i.d.:
yvk � Gðk; sÞ ð17Þ
where k and s are the known mean and degree of freedom parameters (see [29] for parameteri-
zation of the Gamma distribution). We assume that the patient-level coefficients are indepen-
dent of the population-level coefficients given the hyperparameters.
Finally, we use a conjugate Wishart distribution for the error precision matrix ö:
L � WishartðK; nÞ ð18Þ
where K is the R × R scale matrix and ν is the degree of freedom parameter, both assumed to
be known.
2.2 Posterior inference
We use Markov Chain Monte Carlo (MCMC) to generate draws from the posterior distribu-
tion, specifically, a Gibbs sampler with parameter expansion [31]. A common computational
challenge of Gibbs sampling for hierarchical regression models is that the sampler can be very
slow when there is high dependence between the coefficients and their variance parameters.
For our model, there is strong dependence between vn and its precision parameters óv: when
Bayesian VAR for PLPM
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the current draw ofóv is large, the next draw of vn will be small, which in turn makes the next
draw ofóv even larger, and so on, so the sampler can take an impractically long time to explore
the entire parameter space.
Using parameter-expansion allows us to reduce inter-parameter correlations and speeds
convergence. Specifically, we add an element-wise multiplicative factor ċ to vn (i.e., multiply
ċk to vnk, k = 1, . . ., R2 p) and draw ċ just like other parameters. In this case, when the current
draw ofóv is large, the next draw of vn will be small, but the next draw of ċ will be large, which
results in the next draw of vn in a normal range. Thus, the expanded parameterization allows
the Gibbs sampler to move in more directions and avoid getting stuck. These new parameters
have no meaning and are not identified in the posterior distribution. However, we are not
interested in either ċ or vn. Rather, the subject-level parameters in this new parameterization
become v�n ¼ ċ � vn where � stands for element-wise multiplication (see S1 Appendix for
parameter expansion and S2 Appendix for detailed descriptions of the full conditionals used in
the posterior sampling).
After obtaining the posterior distributions, we use the posterior modes as the point esti-
mates for the parameters in the model. Using posterior modes as point estimates induces spar-
sity, and is equivalent to the estimates given by the penalized likelihood methods such as Lasso
[30] [32]. Here we use the values with the highest empirical density as the modes of the poste-
rior distribution. This is a crude approach to find the posterior modes but is computationally
efficient for problems with many parameters.
Finally, we use AIC as a criterion to select the optimal order of the VARmodel.
3 Application 1: Predicting substance use craving, negative affect,
and tobacco use among young adults in recovery
College and university students experience high rates of substance use disorders, with 22.9%
meeting the diagnostic criteria versus 8.5% of the general population (National Center on
Addiction and Substance Abuse at Columbia University [CASA], 2007). Recognition of this
problem has led at least 20 colleges and universities to develop collegiate recovery communities
(CRC) [33] that provide comprehensive recovery support services and one of these communi-
ties provided the diary data for the Zheng et al. (2013) study [22]. Day-to-day associations
among substance use craving, negative affect (i.e., emotional discomforts such as “stressed,”
“upset,” “scared,” “hostile,” and “irritable”), and tobacco use among 30 college students who
are smokers and in 12-step recovery from drug and alcohol addictions are analyzed in this
study. The 12-step program was first created by Alcoholics Anonymous (www.aa.org) and is a
frequently used treatment modality for various types of addictions. The intraindividual vari-
ability of relevant psychological states combined with the “one day at a time” nature of sus-
tained abstinence warrants a day-to-day investigation of substance use recovery. Zheng et al.
(2013) fit first-order vector autoregression models to each individual predicting daily levels of
substance use craving, negative affect and tobacco use.
Extensive research has established the relevance of craving, negative affect, and tobacco use
as key criteria in recovery research (e.g., [34]). In turn, negative affect is believed to be a predic-
tor of craving, and tobacco use is both an important correlate of substance use and craving and
a serious public health risk in its own right. Whether tobacco or other substance use (e.g., alco-
hol and drugs) has any beneficial effects for persons in recovery remains an open question.
Quantifying the bidirectional associations among these variables serves as a secondary goal of
Zheng et al. (2013) study.
Zheng et al. (2013) present a series of conclusions finding overall that the study revealed
“substantial person-level heterogeneity in the day-to-day processes that challenge continued
Bayesian VAR for PLPM
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abstinence within a college recovery community, providing a picture of accumulated daily
recovery risk that could threaten abstinence over both the short and long term.”
3.1 Data and preprocessing
The original data in Zheng et al. (2013) comprise 55 adult addict patients from CRC at a
Southwestern university. In this study, we included 25 patients from the same sample, exclud-
ing 12 of the 55 who are non-smokers, 4 whose diary records exhibit no day-to-day variance,
and 14 who have 3 or more missing daily records. All participants were fully anonymized
before accessing the data. All are non-Hispanic White. All had received professional alcohol/
drug dependency treatment. All had received inpatient care, most for 3 months or more. All
considered themselves 12-step group members and reported that they read 12-step literature
and applied the steps to their lives on a daily basis. Participants provided an average of 25.56
days’ worth of data each (ranging from 10 to 33 days), with the average participant missing 0.8
days (ranging from 0 to 2 days). Notice that we used slightly different criteria than Zheng et al.
(2013) to include the patients, leading to a slightly different sample in the current study.
Tobacco use. Daily tobacco use was measured with one item asking, “How many cigarettes
did you smoke today?” Responses ranged from 0 (no cigarettes), 1 (1 or 2), 2 (2 to 5), 3 (5 to
10), 4 (half pack) to 5 (full pack plus).
Substance use craving. Daily substance use craving was measured with seven items modified
from the Desires for Alcohol Scale and the Alcohol Urges Questionnaire to accommodate
daily assessment and polydrug use. A sample item reads, “For a moment today I missed the
feeling of drinking or drugging.” Responses were 1 (strongly disagree) to 5 (strongly agree).
Negative affect. Zheng et al. (2013) used the 10-item negative affect scale from the Positive
and Negative Affect Schedule to assess daily negative affect. Example emotions including
“Stressed,” “Upset,” “Scared,” “Hostile,” and “Irritable”. Responses ranged from 1, very slightly
or not at all to 5, very much. Zheng et al. (2013) provided descriptive statistics for the three var-
iables and the number of observations of each participant.
Our pre-processing step includes missing data imputation using the mean of the non-miss-
ing consecutive days, log-transformation of all three variables to improve normality, standardi-
zation to mean 0 and variance 1 and removal of linear trend for each time series for each
patient by regressing individual variables against the “day” variable (i.e., from 1 to the total
number of days for a participant) and taking the residuals.
3.2 Hyperpriors used in the model
We used weakly informative priors that are conjugate but almost flat on the parameter space
[29]. In particular, we assume l2
1;k and ĕ2,k, k = 1, . . ., R2 p follow î(1, 0.001) and î(1, 0.01)
distributions respectively. The diagonal elements of óv are assumed to follow î(1, 0.01).
The precision matrix of the error term ö is assumed to follow Wishart((R − 1)IR, 1). We
assume the multiplicative variables (see S1 Appendix) follow a diffuse normal distribution:
MVNð0; 100IR2pÞ.
3.3 Criterion to assess model performance
We use prediction accuracy as a criterion to assess the performance of the proposed sparse
hierarchical VAR model. We compare it with the patient-specific VARmodel used in Zheng
et al. (2013) and regularized linear regression model, a state-of-the-art machine learning-based
approach for patient level prediction modeling (see, for example, [35], [36]). In particular, all
Bayesian VAR for PLPM
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but the last daily record of each individual patient are used to train the model and the last daily
record is used as a test set.
We use the posterior predictive distributions to predict the test data for the Bayesian model
(see [26] for details about this procedure). Specifically, each individual sample of the 1-step
ahead forecast for subject n = 1, . . ., N is generated by the posterior samples of the VAR coeffi-
cients and the error precision matrix:
y^ n;Tnþ1 ¼
Xp
i¼1
A^niyn;Tn þ ŀ^n;Tnþ1; ð19Þ
where ŀ^n;Tnþ1 is drawn from a multivariate normal distribution with mean 0 and precision
matrix equal to one posterior sample of ö
ŀ^ n;Tnþ1 � MNð0; L^Þ: ð20Þ
Posterior means and the 2.5-th and 97.5-th posterior percentiles of these posterior predic-
tive samples are used as point and interval estimates of the prediction. For the patient-specific
VARmodel, maximum-likelihood estimates (MLE) are used to predict the test observation for
each individual patient. For the regularized linear regression model, elastic-net regularization
(with equal weights on L1 and L2 norms) was fitted for each patient to predict the current value
of each individual variable based on the previous values of all three variables. 3-fold cross vali-
dation in conjunction with the “one standard error” criterion was used to train the model,
select the tuning parameters and perform the future data prediction (the same procedure was
utilized in [35]). Mean squared error (MSE) and coverage probability (obtained by the per-
centage of the test data points that are contained in their 95% predictive intervals) are used to
assess prediction accuracy on the test set for all three models. Predictive intervals are obtained
by the posterior quantiles for the the Bayesian model and by the bootstrap quantiles for the
regularized linear regression model [37]. Note that using posterior modes for parameter esti-
mation enforces sparsity and interpretation and using posterior means minimizes mean
squared error (MSE) for the forecasting [26].
3.4 Results
3.4.1 Posterior sampling and order selection. We fit two hierarchical VAR models with
order one and two, respectively. The posterior sampling procedure was implemented in R.
Specifically, we ran 10,000 iterations across 4 chains and used the first half of the iterations as
warmup iterations. The second half was thinned by every 20 iterations to diminish the auto-
correlation in the posterior samples, ending up with 500 samples per chain for posterior
inference. All 4 chains mixed well and converged to similar stationary distributions for all
parameters (the maximum of the Gelman-Rubin statistics [31] over all parameters in the
model is 1.028). No serial correlations are found in the chains. The number of parameters for
this example is about 300 for VAR(1) and 600 for VAR(2). (See S1 Fig for diagnostic plots of
the mixing and S2 Fig for the autocorrelation of the chains for some of the parameters in the
population-level coefficients).
For this particular example, the model with order one resulted in a smaller AIC (3027.951)
and is favored. Since the second order model underperformed the first order model
(AIC = 3466.319), we did not pursue higher orders. We note that Zheng et al. (2013) fit VAR
(1) models to each individual patient. In fact, since there is one patient who has only 9 days of
daily records in the training data, maximum likelihood estimation of models of higher order
than one results in singularity problems requiring a Bayesian and/or regularized approach.
Bayesian VAR for PLPM
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3.4.2 Population-level coefficients and between-patient heterogeneity. Fig 1 shows the
posterior modes of the population-level coefficients, i.e., the posterior modes of the lag-1 asso-
ciations between tobacco use, substance craving and negative affects. In the circles, T repre-
sents tobacco use, N represents negative affect and C represents craving. The arrows and the
numbers next to the arrows display the values of the posterior modes of the lag-1 associations
between the three variables. In particular, the red arrows show positive associations while blue
arrow shows the negative one. The solid arrows represent the “significant” associations. Specif-
ically, the pink arrow indicate that a 90% interval does not contain 0. The transparent arrows
show the associations that are not significant. One can see from Fig 1 that tobacco use in the
previous day has the strongest positive effect on the tobacco use in the current day. This sug-
gests that when there is 1 unit increase in tobacco use in the previous day, there seems to be an
increase (0.137 on the log scale) in tobacco use in the current day. The second and third stron-
gest effects are negative affect in the previous day on the negative affect (0.048) and substance
use craving (0.035) in the current day. Moreover, craving in the previous day has a small nega-
tive effect on itself in the current day (-0.003). These posterior modes of the lag-1 associations
constitute a predictive model for predicting tobacco use, negative affect and craving in the cur-
rent day based on the values of these variables in the previous day on the general population
level.
3.4.3 Patient-level coefficients. Fig 2 shows the posterior modes of the patient-level coef-
ficients. In these plots, the solid red arrow indicates that a 95% posterior interval does not con-
tain 0. We see that several lag-1 associations between the three variables of interest are zero for
most patients, including negative affect and craving in the previous day on themselves in the
Fig 1. Posterior modes of the population-level coefficients. T = tobacco use, N = negative affect, C = craving.
Red = positive, blue = negative. Solid = significant coefficients (red: ċ = 0.05; pink: ċ = 0.1), transparent = non-
significant coefficients.
https://doi.org/10.1371/journal.pone.0208082.g001
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current day, as well as negative affect in previous days on tobacco use and craving in the
current day. For the non zero associations, tobacco use in the previous day has an effect on
tobacco use in the current day for all patients. Craving in the previous day also has an effect on
tobacco use in the current day for almost all patients. These associations vary across different
patients in terms of both sign and magnitude.
The advantage of the sparsity induced by the elastic-net prior over the existing patient-
specific VAR model is that it reduces spurious relationships between the variables [38] and
only selects the variables that are the most predictive for the outcome. Such selection of impor-
tant variables vary across individual patients (for example, different patterns of associations
between the variables can be found for patient 1, 2 and 18). This aids interpretation and
Fig 2. Posterior modes of the patient-level coefficients. T = tobacco use, N = negative affect, C = craving. Red = positive, blue = negative.
Solid = significant coefficients (red: ċ = 0.05; pink: ċ = 0.1), transparent = non-significant coefficients.
https://doi.org/10.1371/journal.pone.0208082.g002
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provides the most important relationships between the three variables for each individual
patient, leading to a useful insight for personalized treatment. In contrast, the patient-specific
VAR model does not provide sparse estimates and thus no insights of important variable asso-
ciations for individual patients are obtained. Further, our elastic-net prior utilizes adaptive
shrinkage in the coefficient estimates (i.e., different L1 and L2 tuning parameters for different
coefficients) while the regularized linear regression model uses the same tuning parameters for
all coefficients. The latter leads to aggressive shrinkage in the coefficient estimates. In fact, most
of the estimated coefficients given by the regularized linear regression model are zero, meaning
that no variables are selected for the majority of the patients. Therefore, compared to the
patient-specific VAR model that has no shrinkage and the regularized linear regression model
that has aggressive shrinkage, our model provides decent amount of shrinkage and improves
interpretation (see S1 Table for the proposed Bayesian VARmodel, S2 Table for the patient-
specific VAR model and S3 Table for the regularized linear regression model, respectively).
Fig 3 shows the posterior modes of the standard deviation of the patient-level coefficients
(i.e., the square root of the inverse of the diagonal elements ofóv). The solid arrows show
the associations with large patient-level heterogeneity: the largest one is the effect of previous
tobacco use on current tobacco use, followed by previous craving on current negative affect
and tobacco use. This is consistent with the findings in Fig 2. Note that the patient-specific
VARmodel and the regularized linear regression model do not provide quantification or
interpretation of the patient-level heterogeneity.
3.4.4 Gender and age group analysis. To further investigate what constitutes the patient-
level heterogeneity for each of the associations between the three variables, we separate the
Fig 3. Posterior modes of the standard deviation of the patient-level coefficients. T = tobacco use, N = negative
affect, C = craving. The first three largest standard deviations are shown in solid arrows.
https://doi.org/10.1371/journal.pone.0208082.g003
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entire sample of 25 participants by gender and age into 3 groups: young female, young male
and old male. We then look at the distribution of the posterior modes of the patient-level lag-1
coefficients (i.e., the arrows in the panels in Fig 2) within each group. The first two groups
have age ranging from 18 to 21 years old and the third group from 22 to 32 years old (there is
no female students who are older than 22 years old). This separation provides balanced sample
sizes in the three groups: 8, 8 and 9, respectively. Fig 4 shows the distribution of the posterior
modes of the patient-level lag-1 coefficients separated by the three groups. Each panel repre-
sents one group. Each boxplot represents the distribution of a distinct lag-1 association
between a pair of variables (i.e., the tick name “X=>Y” represents the lag-1 association of vari-
able X in the previous day on variable Y in the current day). Note that the y-axis range is trun-
cated (removing one outlier from the distribution of the autocorrelation of tobacco use in the
young female group and one in the old male group) for better visualization.
We can see that for the autocorrelation of tobacco use in the previous day on tobacco use in
the current day (i.e., the pink box in the first column), the three groups tend to have similar
medians with the young female group having a slightly higher median than the other two
groups. However, the young male group has the greatest variance than the other two groups.
Many of them also have strong negative patient-level coefficients, as apposed to the old male
group, which has strong positive patient-level coefficients. This suggests that while increase
in tobacco use in the previous day tends to increase tobacco use in the current day for the gen-
eral population (as is displayed by Fig 1), the young male group tends to have less increase in
the current day than the general population while the old male group tends to have greater
increase in the current day than the general population. In other words, the continuous use of
tobacco across days seems to be greater among older males.
Further, for the effect of craving in the previous day on negative affect in the current day
(i.e., the purple box in the eighth column), the old male group seems to have a higher value
than the other two groups. This suggests that for males older than 22 years, more craving in
the previous day correlates to more negative affect in the current day than young females and
young males. Moreover, for the effect of craving in the previous day on tobacco use in the
current day (i.e., the blue box in the seventh column), the old male group has lightly greater
Fig 4. Distribution of the posterior modes of patient-level coefficients in different gender and age groups. T = tobacco use, N = negative affect,
C = craving. Each panel represents one group. Each boxplot shows the lag-1 association between a pair of variables (the tick name “X=>Y” represents the
lag-1 association of variable X in the previous day on variable Y in the current day).
https://doi.org/10.1371/journal.pone.0208082.g004
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variance than the other two groups. This suggests that the effect of craving in the previous day
on tobacco use in the current day can be more different between individual old males than
between the younger participants.
3.4.5 Prediction accuracy. Table 1 shows the MSE’s of the proposed Bayesian hierarchical
model compared with the patient-specific VAR model and the elastic-net regularized linear
regression model (the % reduction in MSE is displayed in italic font). We see that the hierar-
chical model improved the accuracy of the prediction on both competitor models. The overall
mean square error averaged over all three variables is reduced, respectively, by 25% and 8%
using the Bayesian model relative to the patient-specific VAR model and the regularized linear
regression model. For the individual variables, predictive accuracy is the same or better for all
three variables with the mean square errors reduced by 17% and 12% for tobacco use, 4% and
0% for negative affect, and 38% and 12% for craving. This shows the advantage in terms of pre-
dictive accuracy of the hierarchical model which pools the information across all patients and
induces regularization in parameter estimation.
Fig 5 shows the prediction intervals for all subjects using the proposed Bayesian model, the
patient-specific maximum-likelihood estimates and the regularized linear regression model.
The squares represent the regularized linear regression model, the circles represent the
patient-specific MLE’s, and the triangles represent the Bayesian estimates. The lines going
through the dots show the 95% intervals. Red stars show the true test observations. The num-
bers of time points in the training data for each patient are shown as well. We see that for mod-
erately large sample sizes (above 20 time points), the point estimates are quite similar for all
three models. However, for the subject with small sample size (subject 14 has only 9 training
observations), Bayesian prediction is remarkably better than the MLE for craving. Both the
Bayesian model and the regularized linear regression model enforce elastic-net regularization
so the point estimates obtained by both models are shrink towards 0.
The estimated coverage probabilities of 95% predictive intervals are, respectively, 97%, 93%
and 33.3% for the Bayesian model, the patient-specific VAR model and the regularized linear
regression model. For a nominal level of 95%, we would expect about 95% of the predictive
intervals to contain the true values. Both the Bayesian model and the patient-specific VAR
model are close to the nominal level, whereas the regularized linear regression model is sub-
stantially undercovered. Further, 68% of the Bayesian intervals are narrower than those given
by the patient-specific VARmodel. This shows that the Bayesian method can not only provide
more accurate point estimates but also a more satisfactory range estimate as well. Note that the
majority of the intervals (more than 95%) given by regularized linear regression model are nar-
rower than the other two methods. Both the undercover issue and the short length of these
intervals are due to the aggressive nature of the shrinkage of this model.
Table 1. Application 1:MSE of the Bayesian hierarchical VARmodel, the patient-specific VARmodel and the regularized linear regression model.
Model Overall MSE MSE by Variable
T N C
Bayesian VAR model .722 .459 .704 1.00
Patient-specific VAR model .964 .554 .731 1.608
% Reduction 25.1% 17.1% 3.7% 37.7%
Regularized linear model .787 .524 .705 1.133
% Reduction 8.3% 12.3% 0.1% 11.5%
T = tobacco use, N = negative affect, C = craving.
https://doi.org/10.1371/journal.pone.0208082.t001
Bayesian VAR for PLPM
PLOS ONE | https://doi.org/10.1371/journal.pone.0208082 December 14, 2018 13 / 27
Fig 5. Posterior means and 95% intervals for the 1-step ahead prediction. T = tobacco use, N = negative affect, C = craving. The squares
represent the regularized linear regression model, the circles represent MLE’s and the triangles represent the Bayesian estimates. The lines show the
95% intervals. Red stars are the true future observations. Number of observations (Tn) for each subject is shown in the subtitle.
https://doi.org/10.1371/journal.pone.0208082.g005
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4 Application 2: Predicting functional somatic symptoms (FSS) and
psychological discomforts
Approximately 20% to 50% of the physical symptoms presented in primary care and hospital
settings cannot be fully explained by organic pathology [39] [40] [41]. These symptoms are
commonly referred to as functional somatic symptoms (FSS). Previous studies in epidemiol-
ogy have suggested greater stress [42] [43] [44] and other psychological discomforts [45] [46]
in people who suffer from FSS’s than those who do not. Utilizing patient diary databases, a few
studies have shown cross-relationship between stress and FSS’s in both directions within sub-
jects over time [47] [48].
To investigate bidirectional relationship and temporal precedence between stress and FSS’s
within individual patients, van Gils et al. (2014) adopted a VARmodeling framework on data
from a diary study with patients who had multiple, persistent FSS’s, including external and
internal body pain and other symptoms related to the autonomic nervous system [23]. A
patient-by-patient Granger causality analysis of stress and several FSS’s showed that an
increase in one or more FSS’s were found to be significantly predictable by preceding (mostly
first-lag) increase in stress for 30% of the patients, and reverse association in 15% of the
patients. Substantial between-patient heterogeneity in the lagged associations between the
FSS’s and stress was also reported. We re-analyze the same dataset using the proposed model.
4.1 Data and the preprocessing
26 patients with persistent FSS’s and psychological discomforts were recruited by medical
practitioners in a 12-week study between January 2004 and February 2006. Standard handheld
personal digital assistant (PDA) computers with the Palm operating system were used to
record daily diary on 14 FSS’s (muscle pain, joint pain, back pain, headache, abdominal pain,
pelvic pain, bowel symptoms, dyspepsia, nausea, tight throat, chest pain, weakness, numbness
and palpitations) and 5 psychological discomforts (stress, fatigue, anxiety, depression and ill-
ness concern). Patients entered 1-3 records on each day, with each data entry consisting of 3
most severe symptoms out of the 14 FSS’s and all 5 psychological discomfort measures (all
patients entered the same 3 symptoms during the entire study period). All participants were
fully anonymized before accessing the data.
FSS’s. Diary questions with respect to FSS’s were phrased as follows: “How much have you
been bothered by symptom X? Please mark a point on the line between severe symptom X and
no symptom X at all.” (1-150).
Psychological discomforts. The level of stress and other psychological discomforts were
assessed using the following question: “How stressful (fatigue, anxiety-arousing, depressing,
illness-concerning) are people and things around you? Please mark a point on the line between
very stressful (fatigue, anxious, depressed, illness-concerned) and not stressful (fatigue, anx-
ious, depressed, illness-concerned) at all.” (1-150).
Since only 3 out of the 14 FSS’s were recorded for each patient, most of the FSS’s were
recorded by a very small number of patients (10 out of the FSS’s were recorded by less than 3
patients and 1 FSS by 9 patients). We therefore use subsets of the data on 4 of the FSS’s (head-
ache, joint pain, bowel symptoms, muscle pain) that were recorded by the greatest number of
patients (N = 12, 12, 10, 15, respectively). All patients in these subsets are included in the analy-
sis. The age of the patients included in the four models ranges from 29 to 59 years old and
there is only 1 male in the first 3 models and 4 males in the fourth model. For each of the 4
FSS’s, we extend the previous work where the relationship between one FSS and stress was
considered [23], and fit the proposed Bayesian VAR model on the FSS and all 5 psychological
discomfort variables. This results in 4 models, each of which considers 6 variables. The average
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(range) length of diary records for the 4 FSS’s are, respectively, 90 (64-126), 89 (64-131), 86
(64-109), 90 (83-126) days, with average (range) number of missing daily records 9 (0-37), 9.5
(0-47), 6 (0-24), 4.4 (0-37), respectively.
The pre-processing of the data included: 1) averaging of the variables for each day and
each patient to ensure one observation per day per patient, if there are more than one records
entered on the same day for the same patient; 2) missing value imputation using moving aver-
age imputation embedded in R package ‘imputeTS’ (https://cran.r-project.org/web/packages/
imputeTS/index.html); 3) log-transformation of each of the 6 variables to improve normality;
4) standardization to mean 0 and variance 1 and removal of linear trend for each time series
for each patient (the same as in Section 3). Note that we use a slightly more elaborate imputa-
tion procedure here because there are more missing observations than those in the first
application.
We use the same posterior sampling strategy and hyperpriors in Section 3 for this applica-
tion. We use the last 10 observations of each patient as test data and the remainder training
data. 1-step ahead forecasting was performed using the same technique in Section 3 and h-step
ahead forecasting, h = 2, . . ., 10, was performed using the recursive algorithm (see [26] for
details). Posterior modes of the parameters are used for statistical inference. Assessment of
prediction accuracy (i.e., MSE of the posterior means and coverage probabilities of 95% pre-
dictive intervals) and model order selection (i.e., AIC) are the same as Section 3.
4.2 Results
4.2.1 Posterior sampling and order selection. For each of the 4 models, we ran 20,000
iterations across 4 chains and used the second half of the iterations (thinned by every 40 itera-
tions, yielding 250 samples per chain) for posterior inference. All chains mixed well and con-
verged to the stationary distribution (the maximums of the Gelman-Rubin statistics over all
parameters are, respectively, 1.016, 1.023, 1.018, 1.026 for the 4 FSS’s). No serial correlations
are found in the chains. VAR(1) models outperformed VAR(2) models with smaller values of
AIC across all 4 models (the VAR(1) models for the 4 FSS’s have AIC values 5963.7, 6166.4,
4725.1, 7419.5, respectively, and the VAR(2) models 7054.0, 7212.4, 5719.7, 8670.4). We there-
fore favor VAR(1) models in this application (see S3 to S10 Figs for diagnostic plots for the
first 9 parameters in the population-level coefficients for each of the 4 models).
4.2.2 Population-level coefficients. Fig 6 displays the posterior modes of the population-
level coefficients for the 4 models (panel (a)-(d) represent FSS = headache, joint pain, bowel
symptom and muscle pain, respectively). The coefficient at the r-th row and the c-th column
in each panel represents the effect of the c-th variable in the previous day on the r-th variable
in the current day. Significant coefficients (at level ċ = 0.1) are in bold font. Purple box on
each panel represents the effect of the psychological discomforts in the previous day on the
FSS in the current day; blue box represents the reverse effect of FSS in the previous day on the
psychological discomforts in the current day.
Inspection of Fig 6 indicates that most FSS’s and psychological discomfort variables have
positive effects on themselves. Most of the cross-relationships between FSS’s and psychological
discomforts are positive and the magnitudes are smaller than the autocorrelations of the vari-
ables. The strongest cross-associations between FSS’s and psychological discomforts include
the effect of headache in the previous day on fatigue in the current day for patients who
reported headache, the effect of joint pain in the previous day on illness concern in the
current day for patients who reported joint pain, the effect of stress in the previous day on
bowel symptoms in the current day for patients who reported bowel symptoms, and the effect
of anxiety/muscle pain in the previous day on muscle pain/illness concern in the current day
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for patients who reported muscle pain. Moreover, there are significant associations between
the psychological discomfort variables, including the effect of fatigue on depression for
patients who reported joint pain and anxiety on fatigue and depression for patients who
reported muscle pain.
4.2.3 Between-patient heterogeneity. Fig 7 displays the posterior modes of the
standard deviations of the patient-level deviations for the 4 models (Panel (a)-(d) represent
FSS = headache, joint pain, bowel symptom and muscle pain, respectively). The highest
between-patient heterogeneity lies in the autocorrelation of fatigue for patients who reported
headache, joint pain or bowel symptoms. For cross-relationships between the FSS’s and the
Fig 6. Application 2: Posterior modes of the population-level coefficients for the 4 FSS’s. Panel (a)-(d) display FSS = headache, joint pain, bowel
symptoms and muscle pain, respectively. The coefficient at the r-th row and the c-th column in each panel represents the effect of the c-th variable in the
previous day on the r-th variable in the current day. Significant coefficients (at level ċ = 0.1) are in bold font. Purple box on each panel represents the
effect of the psychological discomforts in the previous day on the FSS in the current day; blue box represents the effect of FSS in the previous day on the
psychological discomforts in the current day. Head = headache, Join = joint pain, Bowe = bowel symptoms, Musc = muscle pain, Fati = fatigue,
Stre = stress, Depr = depression, Anx = anxiety, Conc = illness-concern. Color scale ranges from -0.5 to 0.5.
https://doi.org/10.1371/journal.pone.0208082.g006
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psychological discomforts, the highest between-patient heterogeneity was present in the
effect of headache on illness-concern and depression and the effect of anxiety on headache
for patients who reported headache, the effect of illness-concern and depression on joint
pain for patients who reported joint pain, and the effect of muscle pain on stress and depres-
sion and the effect of stress on muscle pain for patients who reported muscle pain. The last
finding is consistent with the previous studies which have found substantial between-subject
heterogeneity in the association between stress and FSS’s [49]. Note that neither the patient-
specific VAR model nor the regularized linear regression model quantifies the between-
patient heterogeneity.
Fig 7. Application 2: Posterior modes of the standard deviations of the patient-level deviations. Posterior modes of the standard deviations of the
patient-level deviations for the 4 FSS’s. Panel (a)-(d) display FSS = headache, joint pain, bowel symptoms and muscle pain, respectively. The number at
the r-th row and the c-th column in each panel represents the standard deviation of the effect of the c-th variable in the previous day on the r-th variable
in the current day. Purple box on each panel represents between-patient heterogeneity in the effect of the psychological discomforts in the previous day
on the FSS in the current day; blue box represents the between-patient heterogeneity in the effect of FSS in the previous day on the psychological
discomforts in the current day. Head = headache, Join = joint pain, Bowe = bowel symptoms, Musc = muscle pain, Fati = fatigue, Stre = stress,
Depr = depression, Anx = anxiety, Conc = illness-concern. Color scale ranges from 0 to 0.3.
https://doi.org/10.1371/journal.pone.0208082.g007
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4.2.4 Age group analysis. To further investigate what constitutes the substantial between-
patient heterogeneity, we separate the patients into two groups by age: a young group with age
ranging from 29 to 44 years old and an old group with age ranging from 44 to 59. The sample
sizes for the younger patients are 6, 8, 2 and 7 for the 4 FSS’s respectively (note that we choose
44 years old to be the cutoff in order to ensure most FSS’s to have balance sample sizes of the
two groups). We did not separate the patients by gender because the majority of the patients
are female (there is only 1 male in the first 3 FSS models and only 4 males in the fourth FSS
model) and separation by gender will lead to very imbalanced subsets. Fig 8 displays the distri-
bution of the posterior modes of patient-level coefficients for the two groups. In each panel,
the boxplots represent the lag-1 patient-level coefficients between the FSS and the psychologi-
cal discomforts. The ticks on the top line mark the lag-1 autocorrelations of the FSS and the
psychological discomforts. The blue ticks on the bottom line mark the effect of the FSS in the
previous day on each individual psychological discomforts in the current day. The purple ticks
mark the reverse effect of psychological discomforts on FSS (the colors of the ticks are consis-
tent with Figs 6 and 7).
Inspection of Fig 8 indicates that the young group has a higher variability in the autocorre-
lations and the cross-associations of the variables in general. Specifically, younger patients
have greater variability in the autocorrelation of fatigue (i.e., the brown box in the eighth col-
umn in each panel) than the old group across all 4 FSS’s. In other words, the large between-
patient heterogeneity in the autocorrelation of fatigue (as is shown in Fig 7) is mainly
explained by the variabilities in the young group. This suggests that while some young patients
develop much greater fatigue in the current day after experiencing increased fatigue in the pre-
vious day, others may have much less fatigue in the current day. In contrast, the old group
tends to have a smaller increment in fatigue in the current day after experiencing increased
fatigue in the previous day for most of the FSS’s. Moreover, for the autocorrelation of bowel
symptoms (i.e., the pink box in the first column in the panels in the third row), the young
group has a majority of negative coefficients whereas the old group has a majority of positive
coefficients. This suggests that when the bowel symptoms increased in the previous day, the
young group tends to have less bowel symptoms in the current day than the general popula-
tion, whereas the old group tends to have more bowel symptoms than the general population
in the current day.
For the cross-relationships, the young group seems to have larger variability than the old
group on the effect of previous-day headache on current-day depression (i.e., the light pink
box in the fourth column in the panels in the first row), whereas the old group seems to have a
larger variability than the young group on the effect of previous-day headache on current-day
illness-concern (i.e., the orange box in the sixth column in the panels in the first row). Further,
the young group seems to have a majority of positive effects of previous-day stress on current-
day muscle pain while the old group has a majority of negative effects (i.e., the pink box in the
third column in the panels in the fourth row). While these cross-associations have been shown
to have large between-patient heterogeneity (as is indicated by Fig 7), different age groups tend
to contribute different amount of variability in these cross-relationships.
4.2.5 Prediction accuracy. Table 2 displays the performance of predicting the10 test data
points using the Bayesian VARmodel, the patient-specific VARmodel and the regularized lin-
ear regression model for the 4 FSS’s. Estimated MSE’s and coverage probabilities are shown
for each single FSS. % reduction in MSE and % shorter predictive intervals given by the Bayes-
ian model relative to the other two models are shown in italic font. Fig 9 displays the h-step
forecasting, h = 1, . . ., 10, on headache for all patients who reported this FSS. The black, blue
and green lines display, respectively, the prediction given by the Bayesian model, the patient-
specific VARmodel and the regularized linear regression model. Solid lines represent the
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point estimates and dashed lines the predictive intervals given by the three methods. Red dots
show the true values of the test data points.
We can see that both the Bayesian model and the patient-specific VARmodel performed
similarly, with the Bayesian model slightly better across all 4 FSS’s. This is probably due to the
Fig 8. Application 2:Distribution of posterior modes of the patient-level coefficients. Each boxplot displays the patient-level coefficients of the lag-1
associations between the FSS’s and psychological discomforts. The left and right columns represent the young group (less than or equal to 44 years old)
and the old group (greater than 44 years old). The ticks on the top line in each panel mark the lag-1 autocorrelations of the FSS and the psychological
discomforts. The blue ticks on the bottom line mark the effect of the FSS in the previous day on psychological discomforts in the current day, and the
purple ticks mark the reverse effect of psychological discomforts on FSS. H = headache, J = joint pain, B = bowel symptoms, M = muscle pain,
F = fatigue, S = stress, D = depression, A = anxiety, C = illness-concern.
https://doi.org/10.1371/journal.pone.0208082.g008
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Table 2. Application 2: Prediction accuracy of the Bayesian model, the patient-specific VARmodel and the regularized linear regression model.
Headache Joint Pain Bowel Symptoms Muscle Pain
MSE
Bayesian VAR model 0.741 0.695 0.568 0.698
Patient-specific VAR model 0.744 0.698 0.584 0.704
% Reduction 0.38% 0.52% 2.64% 0.90%
Regularized linear regression model 0.790 0.749 0.609 0.755
% Reduction 6.16% 7.29% 6.68% 7.64%
Coverage probability
Bayesian VAR model 0.963 0.964 0.97 0.964
Patient-specific VAR model 0.954 0.961 0.968 0.958
% Shorter interval 64% 65% 61% 68%
Regularized linear regression model 0.214 0.189 0.22 0.244
% Shorter interval 0% 0% 0% 0%
https://doi.org/10.1371/journal.pone.0208082.t002
Fig 9. Application 2: Posterior means and 95% intervals for predicting headache. Posterior means and 95% intervals for predicting headache for all
patients who reported this FSS using the Bayesian VARmodel, the patient-specific VARmodel and the regularized linear regression model. Each panel
represents one patient (the index shows the h-step forecasting, h = 1, . . ., 10). The black, blue and green lines display, respectively, the prediction given
by the Bayesian model, the patient-specific VARmodel and the regularized linear regression model. Solid lines represent the point estimates and dashed
line the predictive intervals given by the methods. Red dots show the true values of the test data points. Number of observations (Tn) for each patient is
displayed in each panel.
https://doi.org/10.1371/journal.pone.0208082.g009
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fact that the number of observations (Tn, n = 1, . . ., N) for each patient in the training data is
much greater than that in Section 3, so the Bayesian model utilized much more information
contained in the data than in the prior distributions, leading to similar behavior to the maxi-
mum-likelihood approach. Nevertheless, the Bayesian model still outperformed the patient-
specific models in point estimates due to the pooling among patients. Further, the regularized
linear regression model underperformed the other two methods. In fact, the cross-validation
procedure always selected large values for the tuning parameters (i.e., strong regularization in
the estimation), leading to the models that only contained intercepts. This resulted in less satis-
factory prediction and low interpretability for most of the cases.
For the estimated coverage probability, both the Bayesian model and the patient-specific
VARmodel tend to slightly overcover (with the Bayesian model slightly more overcovered),
but the Bayesian model provides shorter predictive intervals due to the shrinkage imposed by
the priors. Similar to the first application, the regularized linear regression model substantially
undercover across all 4 FSS’s.
5 Discussion
In summary, we proposed a novel Bayesian hierarchical VAR model for PLPM. Our model
simultaneously estimates population-level and patient-level coefficients, as well as estimating
between-patient heterogeneity. While previous methods either imposes no sparsity (e.g., the
patient-specific VAR model) or too much sparsity (e.g., the regularized linear regression
model), our model selects the most important predictors that lead to better interpretability
and visualization as well as higher predictive accuracy. Further, while previous studies utilized
ad-hoc approaches such as clustering analysis to qualitatively identify patterns in subgroups
and no quantification of between-patient difference is provided, our model quantifies the
between-patient heterogeneity without loss of information.
Our primary objective was to evaluate the hierarchical approach to patient diary modeling
as compared with the widely-used patient specific models. We included an elastic-net regular-
ized linear model to provide an alternative benchmark. We note that the diary application
could utilize other approaches such as neural networks, support vector machines or random
forest, although the elastic-net approach has been highly competitive in many applications
(see, for example, [50], [51]).
In the examples, we used weakly informative hyperpriors which are conjugate but almost
flat on the parameter space. This provides convenient derivation of the conditionals used in
the Gibbs sampler while enforcing little prior information. We also tried different values of the
hyperparameters but these yielded very similar results.
Furthermore, in the examples, we used posterior modes as parameter estimates for better
interpretability and visualization. However, we also tried posterior median. Due to the fact
that the posterior distributions are symmetric and unimodal for most of the parameters, the
results were very similar in terms of both parameter estimation and future data prediction,
although sparsity in the parameter estimation then no longer exists.
Moreover, we used a relatively simple missing data imputation scheme in the applications.
This is to facilitate computational speed. Certainly more elaborate imputation procedure could
be employed. Due to the fact that there are only a very small portion of missingness in both
applications, different imputation approaches should not lead to drastically different results.
We also notice that the point estimates of the future observations in both applications are
close to zero, while the true values can be quite far away from zero. We suspect two reasons for
this phenomenon: 1) the Bayesian method has bias-variance trade-off, that is, it increases bias
by shrinking the prediction towards zero but greatly reduces variance, leading to smaller
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prediction errors in general; 2) the test data contains a lot of variability and both existing state-
of-the-art models and the proposed model need more covariates to improve prediction. In
future work, we hope to include more covariates (including demographic variables, time infor-
mation such as weekdays or weekends, and activity information in the previous day) that may
be predictive about the outcomes in order to improve the prediction accuracy for cases like
this.
In addition, due to the limited duration of observation in the first application, we used only
1 day as test data for each patient. As such, this probably has limited clinical utility. For the sec-
ond application, however, 10 days (i.e., approximately 16% of the observation duration for
patients with a smaller number of diary records) are used as test data. We believe this can
prove meaningful in clinical practice.
Lastly and equally importantly, in the current application, we derive associations, rather
than causal interpretations, between the variables. If causation is warranted, confounding
must be addressed in the model. Adding covariates, for example, might allow one to address
confounding and derive a more interpretable model for causal inference.
All code that generated the analyses in the paper and the data used in the first application
are provided as online supplementary files (see S1 Rcode and S1 Data, respectively).
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S1 Appendix. Parameter expansion.We implemented a Gibbs sampler algorithm to draw
from the posterior distribution of the proposed model. We adopt a parameter expansion strat-
egy to cope with high correlations among the parameters.
(PDF)
S2 Appendix. Full conditional distributions. To draw from posterior distribution using
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(PDF)
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Application 1. w1 to w9 indicate the 9 population-level coefficients. The 4 chains are displayed
by different colors in each panel.
(TIF)
S2 Fig. Autocorrelation of the chains in the posterior sampling for population-level coeffi-
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are displayed by different colors in each panel.
(TIF)
S3 Fig. Mixing of chains in the posterior sampling for population-level coefficients for
Application 2 FSS headache. w1 to w9 indicate the first 9 population-level coefficients. The 4
chains are displayed by different colors in each panel.
(TIF)
S4 Fig. Autocorrelation of the chains in the posterior sampling for population-level coeffi-
cients for Application 2 FSS headache. w1 to w9 indicate the 9 population-level coefficients.
The 4 chains are displayed by different colors in each panel.
(TIF)
S5 Fig. Mixing of chains in the posterior sampling for population-level coefficients for
Application 2 FSS joint pain. w1 to w9 indicate the first 9 population-level coefficients. The 4
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The 4 chains are displayed by different colors in each panel.
(TIF)
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(TIF)
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ficients. The 4 chains are displayed by different colors in each panel.
(TIF)
S9 Fig. Mixing of chains in the posterior sampling for population-level coefficients for
Application 2 FSS muscle pain. w1 to w9 indicate the first 9 population-level coefficients. The
4 chains are displayed by different colors in each panel.
(TIF)
S10 Fig. Autocorrelation of the chains in the posterior sampling for population-level coef-
ficients for Application 2 FSS muscle pain. w1 to w9 indicate the 9 population-level coeffi-
cients. The 4 chains are displayed by different colors in each panel.
(TIF)
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one patient and each column is for one VAR coefficient.
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S2 Table. Patient-level coefficients obtained by the patient-specific VARmodel. Each row
is for one patient and each column is for one VAR coefficient.
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S3 Table. Patient-level coefficients obtained by the regularized linear regression model.
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S1 Rcode. R code to generate all analysis. This zip file contains all R code to generate the anal-
ysis, including the functions of the posterior sampling procedure for the proposed Bayesian
model and the analysis on the real data.
(ZIP)
S1 Data. Data for Application 1. This zip file contains the data used in the first application.
All datasets are in csv format.
(ZIP)
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